This grant, offered by the Department of Defense (DoD) through its Peer Reviewed Medical Technology/Therapeutic Development Award (TTDA), is designed to support the translation of promising preclinical findings into tangible products for clinical applications. It specifically targets the development of pharmacologic agents, medical devices, or clinical guidance aimed at improving prevention, detection, diagnosis, patient care, and quality of life. The focus is on addressing the critical healthcare needs of military service members, Veterans, and their beneficiaries. Successful applicants must present a clear transition plan outlining how their developed product will advance to clinical trials or market delivery post-award, ensuring a pathway to real-world impact.
Opportunity ID: 234534
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-13-PRMRP-TTDA |
| Funding Opportunity Title: | DoD Peer Reviewed Medical Technology/Therapeutic Development Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 3 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 14, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Oct 08, 2013 |
| Current Closing Date for Applications: | Oct 08, 2013 |
| Archive Date: | Nov 07, 2013 |
| Estimated Total Program Funding: | $6,750,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The PRMRP Technology/Therapeutic Development Award (TTDA) is a product-driven award intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, patient care, and/or quality of life, in at least one of the Congressionally directed FY13 PRMRP Topic Areas. Products in development should be responsive to the health care needs of military service members,Veterans, and/or beneficiaries. The product(s) to be developed may be pharmacologic agents (drugs or biologics), devices, and/or clinical guidance for standard of care. The Principal Investigator (PI) must provide a transition plan (including potential funding and resources) showing how the product will progress to clinical trials and/or delivery to the military or civilian market after the completion of the PRMRP award. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@cdmrp.org
Email:help@cdmrp.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 234534 Full Announcement-1 -> w81xwh-13-prmrp-ttda.pdf
Packages
| Agency Contact Information: | 301-682-5507; help@cdmrp.org Email: help@cdmrp.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00177731 | May 14, 2013 | Oct 09, 2013 | View |
Package 1
Mandatory forms
234534 RR_SF424_1_2-1.2.pdf
234534 PerformanceSite_1_4-1.4.pdf
234534 RR_Budget-1.1.pdf
234534 RR_KeyPersonExpanded_1_2-1.2.pdf
Optional forms
234534 RR_SubawardBudget30-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
